IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B

Conan Chua, Loghman Salimzadeh, Ann T. Ma, Oyedele A. Adeyi, Hobin Seo, Giselle M. Boukhaled, Aman Mehrotra, Anjali Patel, Sara Ferrando-Martinez, Scott H. Robbins, Danie La, David Wong, Harry L.A. Janssen, David G. Brooks, Jordan J. Feld, Adam J. Gehring

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B'. Together they form a unique fingerprint.

Medicine & Life Sciences